323 related articles for article (PubMed ID: 35052770)
1. The Role of Circulating Biomarkers in the Oncological Management of Metastatic Renal Cell Carcinoma: Where Do We Stand Now?
Cinque A; Capasso A; Vago R; Lee MW; Floris M; Trevisani F
Biomedicines; 2021 Dec; 10(1):. PubMed ID: 35052770
[TBL] [Abstract][Full Text] [Related]
2. The Role of Circulating Tumor DNA in Renal Cell Carcinoma.
Bergerot PG; Hahn AW; Bergerot CD; Jones J; Pal SK
Curr Treat Options Oncol; 2018 Feb; 19(2):10. PubMed ID: 29464405
[TBL] [Abstract][Full Text] [Related]
3. Liquid Biopsies in Renal Cell Carcinoma-Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease.
Lakshminarayanan H; Rutishauser D; Schraml P; Moch H; Bolck HA
Front Oncol; 2020; 10():582843. PubMed ID: 33194717
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
5. Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma.
Pal SK; Sonpavde G; Agarwal N; Vogelzang NJ; Srinivas S; Haas NB; Signoretti S; McGregor BA; Jones J; Lanman RB; Banks KC; Choueiri TK
Eur Urol; 2017 Oct; 72(4):557-564. PubMed ID: 28413127
[TBL] [Abstract][Full Text] [Related]
6. Predictive Biomarkers and Novel Targets in the Treatment of Metastatic Renal Cell Carcinoma.
Zhang H; Zhu G
Curr Med Chem; 2021; 28(25):5213-5227. PubMed ID: 33357191
[TBL] [Abstract][Full Text] [Related]
7. Chasing the Role of miRNAs in RCC: From Free-Circulating to Extracellular-Vesicle-Derived Biomarkers.
Mastrolia I; Catani V; Oltrecolli M; Pipitone S; Vitale MG; Masciale V; Chiavelli C; Bortolotti CA; Nasso C; Grisendi G; Sabbatini R; Dominici M
Biology (Basel); 2023 Jun; 12(6):. PubMed ID: 37372161
[TBL] [Abstract][Full Text] [Related]
8. Plasma Circulating Tumor DNA and Clonal Hematopoiesis in Metastatic Renal Cell Carcinoma.
Bacon JVW; Annala M; Soleimani M; Lavoie JM; So A; Gleave ME; Fazli L; Wang G; Chi KN; Kollmannsberger CK; Wyatt AW; Nappi L
Clin Genitourin Cancer; 2020 Aug; 18(4):322-331.e2. PubMed ID: 32046920
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in renal cell carcinoma and their targeted therapies: a review.
Gupta S; Kanwar SS
Explor Target Antitumor Ther; 2023; 4(5):941-961. PubMed ID: 37970211
[TBL] [Abstract][Full Text] [Related]
10. TARIBO trial: targeted therapy with or without nephrectomy in metastatic renal cell carcinoma: liquid biopsy for biomarkers discovery.
Verzoni E; Ratta R; Grassi P; Salvioni R; Stagni S; Montone R; Fucà G; Cappelletti V; Reduzzi C; De Giorgi U; Procopio G
Tumori; 2018 Oct; 104(5):401-405. PubMed ID: 29192741
[TBL] [Abstract][Full Text] [Related]
11. Circulating Non-coding RNAs in Renal Cell Carcinoma-Pathogenesis and Potential Implications as Clinical Biomarkers.
Barth DA; Drula R; Ott L; Fabris L; Slaby O; Calin GA; Pichler M
Front Cell Dev Biol; 2020; 8():828. PubMed ID: 33042985
[TBL] [Abstract][Full Text] [Related]
12. Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.
de Velasco G; Culhane AC; Fay AP; Hakimi AA; Voss MH; Tannir NM; Tamboli P; Appleman LJ; Bellmunt J; Kimryn Rathmell W; Albiges L; Hsieh JJ; Heng DY; Signoretti S; Choueiri TK
Oncologist; 2017 Mar; 22(3):286-292. PubMed ID: 28220024
[TBL] [Abstract][Full Text] [Related]
13. Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma.
Zizzari IG; Napoletano C; Di Filippo A; Botticelli A; Gelibter A; Calabrò F; Rossi E; Schinzari G; Urbano F; Pomati G; Scagnoli S; Rughetti A; Caponnetto S; Marchetti P; Nuti M
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32937860
[TBL] [Abstract][Full Text] [Related]
14. Circulating biomarkers in renal cell carcinoma: the link between microRNAs and extracellular vesicles, where are we now?
Teixeira AL; Dias F; Gomes M; Fernandes M; Medeiros R
J Kidney Cancer VHL; 2014; 1(8):84-98. PubMed ID: 28326253
[TBL] [Abstract][Full Text] [Related]
15. Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implications.
Hahn AW; Gill DM; Maughan B; Agarwal A; Arjyal L; Gupta S; Streeter J; Bailey E; Pal SK; Agarwal N
Oncotarget; 2017 May; 8(20):33614-33620. PubMed ID: 28431395
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial.
Basso U; Facchinetti A; Rossi E; Maruzzo M; Conteduca V; Aieta M; Massari F; Fraccon AP; Mucciarini C; Sava T; Santoni M; Pegoraro C; Durante E; Nicodemo M; Perin A; Bearz A; Gatti C; Fiduccia P; Diminutto A; Barile C; De Giorgi U; Zamarchi R; Zagonel V
Oncologist; 2021 Sep; 26(9):740-750. PubMed ID: 34077597
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care.
Bex A; Gore M; Mulders P; Sternberg CN
BJU Int; 2012 Nov; 110(9):1289-300. PubMed ID: 22624610
[TBL] [Abstract][Full Text] [Related]
18. Single-cell analysis reveals metastatic cell heterogeneity in clear cell renal cell carcinoma.
Liu K; Gao R; Wu H; Wang Z; Han G
J Cell Mol Med; 2021 May; 25(9):4260-4274. PubMed ID: 33759378
[TBL] [Abstract][Full Text] [Related]
19. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature.
Overby A; Duval L; Ladekarl M; Laursen BE; Donskov F
Clin Genitourin Cancer; 2019 Feb; 17(1):e32-e37. PubMed ID: 30268423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
